1 Department of Neurology, ALS Center, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France. david.devos@chru-lille.fr.
2 Department of Medical Pharmacology, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France. david.devos@chru-lille.fr.
3 Department of Neurology, ALS Center, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France.
4 Department of Biostatistics, Lille University, University Hospital Center, Lille, France.
5 Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA4483 IMPECS-IMPact de l'Environnement Chimique sur la Santé humaine, Lille, France.
6 Department of Medical Pharmacology, Lille University, INSERM UMRS_1171, University Hospital Center, LICEND COEN Center, Lille, France.
7 Université François-Rabelais, Inserm U930, Laboratoire de Biochimie, CHRU de Tours, France.
8 CRB/CIC1403, Université de LILLE, Lille, France.
9 APHP, Department of Neurophysiology, Pitié-Salpêtrière Hospital, Paris, France.
10 Centre Constitutif SLA, Tours-Fédération des centres SLA Tours-Limoges, LitORALS, Tours, France.
11 Biomedical Imaging Laboratory, CNRS, INSERM, Sorbonne University, Paris, France.
12 Computational Neuroimaging Group, Academic Unit of Neurology, Trinity College Dublin, Dublin, Ireland.
13 Quanterix, Lexington, Massachusetts, USA.
14 Department of Neurology, Ulm University Hospital, Oberer Eselsberg 45, 89081, Ulm, Ulm, Germany.
15 APHP, Department of Neurology, Paris ALS Center, Pitié Salpêtrière Hospital, Paris, France.
16 ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0AH, UK.
17 School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, West Yorkshire, United Kingdom.
18 Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute Ulster University, C-TRIC, Altnagelvin Hospital, Derry/Londonderry, United Kingdom.